CG
AMAG

Cutler Group’s AMAG Pharmaceuticals AMAG Stock Holding History

Cutler Group’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-1,550
Closed -$20K – 5606
2017
Q4 		$20K Buy
1,550
+300
+24% +$4.52K ﹤0.01% 2577
2017
Q3 		$23K Sell
1,250
-4,300
-77% -$80.1K ﹤0.01% 3022
2017
Q2 		$102K Sell
5,550
-1,800
-24% -$35.7K ﹤0.01% 1852
2017
Q1 		$165K Buy
7,350
+2,400
+48% +$57.5K 0.01% 1340
2016
Q4 		$172K Sell
4,950
-4,136
-46% -$124K 0.01% 1422
2016
Q3 		$222K Sell
9,086
-29,662
-77% -$741K 0.01% 1120
2016
Q2 		$926K Buy
38,748
+35,595
+1,129% +$816K 0.05% 312
2016
Q1 		$73K Sell
3,153
-2,193
-41% -$52K ﹤0.01% 1929
2015
Q4 		$161K Buy
+5,346
New +$173K 0.01% 1357

Other funds holding AMAG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Cutler Group's AMAG Position: Q1 2018 in Review

Cutler Group sold out of AMAG Pharmaceuticals (AMAG) in Q1 2018, closing a stake of 1,550 shares — an estimated $20K sold.

Cutler Group first reported a position in AMAG in Q4 2015 and held it in 9 quarters. The position peaked at $926K in Q2 2016. 170 funds tracked by Wall St. Rank hold AMAG as of Q1 2018.

  • Cutler Group reported no remaining AMAG Pharmaceuticals position as of Q1 2018 after selling out during the quarter.
  • Cutler Group sold 1,550 AMAG Pharmaceuticals shares in Q1 2018, an estimated $20K.
  • Cutler Group first reported a position in AMAG Pharmaceuticals in Q4 2015 and held it in 9 quarters.
  • Cutler Group's AMAG Pharmaceuticals position peaked at $926K in Q2 2016.
  • 170 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q1 2018.

Based on Cutler Group's 13F filing for Q1 2018, filed 11 May 2018.